Clinical surveys with nebulised hypertonic saline (HS) in CF children

. Bernek (Starnberg, Germany), M. Ollmann-Selinger (Gräfelfing, Germany), R. Ledermüller (Starnberg, Germany)

Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Session: Microbiology and antimicrobial strategies in cystic fibrosis
Session type: E-poster session
Number: 696
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
. Bernek (Starnberg, Germany), M. Ollmann-Selinger (Gräfelfing, Germany), R. Ledermüller (Starnberg, Germany). Clinical surveys with nebulised hypertonic saline (HS) in CF children. 696

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis
Source: Eur Respir J 2005; 26: Suppl. 49, 304s
Year: 2005

Comparison of magnesium sulfate to normal saline as a vehicle for nebulized salbutamol in children with acute asthma; a clinical trial
Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives
Year: 2008

Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013


Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


Inhaled hypertonic saline + hyaluronic acid (HSHA) and HS alone in patients with Cystic Fibrosis (CF): a 2 years retrospective analysis in Treviso’s CF Unit.
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017


Nebulised hypertonic saline in the treatment of viral bronchiolitis in infants
Source: ISSN=ISSN 1810-6838, ISBN=, page=160
Year: 2007

Inhalation therapy with hypertonic saline (3%) – A treatment option for airway disease in children?
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Effect of inhaled hypertonic saline solution to treat infants hospitalized with viral bronchiolitis
Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences
Year: 2011


Effectiveness of nebulised hypertonic saline on the respiratory management of children and young people with neuromuscular disease
Source: International Congress 2019 – Innovations in care for chronic respiratory conditions
Year: 2019


Efficacy of hypertonic saline solution in infant with acute bronchiolitis
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


7% hypertonic saline and hyaluronic acid and in the treatment of infants mild-moderate bronchiolitis
Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences
Year: 2011


Is nebulized saline a placebo in COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 184s
Year: 2001

Success rate of sputum induction in the Leicester paediatric severe asthma clinic using nebulised hypertonic saline: A 2-year review
Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring
Year: 2010

RCT Abstract - The effect of inhaled hypertonic saline on lung structure in preschool children with cystic fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Oxygen saturation decrease after both isotonic and hypertonic saline inhalation in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 698s
Year: 2005

Nebulized saline treatment in patients with concomitant asthma and bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021


Nebulized 3% hypertonic saline in the treatment of acute bronchiolitis in infants
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Inhaled fraction and granulometry of hypertonic saline solution Aerosol for the ambulatory management of newborn babies with viral bronchiolitis: size matters.
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018


Hyaluronic acid improves tolerability to 7% hypertonic saline solution in bronchiectasis patients
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018